L'Oreal US settles hair relaxer cancer cases during first trial
Reuters

L'Oreal US settles hair relaxer cancer cases during first trial

By Diana Novak Jones CHICAGO, Nov 16 (Reuters) - Four women who said they were diagnosed with cancer as a result of chemical hair straightening products reached a settlement on Monday with L’Oreal's US subsidiary and other companies during a trial in Chicago, according to their attorneys. The women
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.